FindTrial
Sign In

Study on the Prediction of Postoperative Recurrence and Metastasis Risk in Localized Renal Cell Carcinoma Using Imaging-Pathology-Genomics

Study on the Prediction of Postoperative Recurrence and Metastasis Risk in Localized Renal Cell Carcinoma Using Imaging-Pathology-Genomics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114355
Enrollment
Unknown
Registered
2025-12-10
Start date
2025-09-15
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Cell Carcinoma

Interventions

Postoperative RCC Metastasis Group:None
Postoperative RCC Recurrence Group:None

Sponsors

The Fifth Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.patients following surgical resection for localized renal cell carcinoma; 2.Was diagnosed with renal cell carcinoma based on histopathological and immunohistochemical examination; 3.Preoperative contrast-enhanced urinary CT (16-slice or higher) or multiparametric MRI (T2WI, DWI, DCE-MRI) examinations performed within 20 days prior to surgery; 4.Complete clinical data available, aged >=18 years, with no restrictions on sex.

Exclusion criteria

Exclusion criteria: 1.Images demonstrating substantial noise or artifacts, including motion, ring, or metal artifacts; 2.History of Prior Cancer Treatment; 3.Patients presenting with indistinct tumor boundaries; 4.Cases demonstrating evidence of distant metastasis before surgical intervention.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;Area Under the Curve;—

Countries

China

Contacts

Public ContactWang Guojie

The Fifth Affiliated Hospital of Sun Yat-sen University

wanggj5@mail.sysu.edu.cn+86 756 252 8320

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026